Our Science
Genetically engineered oncolytic immunotherapy with a two-pronged attack on cancer.
December 3, 2019
Cold Genesys CEO Arthur Kuan Named to 2020 Forbes' 30 Uner 30
March 18, 2019
Genetically engineered oncolytic immunotherapy with a two-pronged attack on cancer.
Cold Genesys CEO Arthur Kuan Named to 2020 Forbes' 30 Uner 30